The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Topical Hemostatic Agent Market Research Report 2025
Synopsis
Medical topical hemostatic agent are used in the setting of surgery or trauma as adjuncts to maintain hemostasis. Topical hemostat products include gelatin sponges, collagens, fibrin sealants, and active thrombin preparations. These agents are applied locally to stop blood flow.
Global Medical Topical Hemostatic Agent market is projected to reach US$ 12690 million in 2029, increasing from US$ 8350 million in 2022, with the CAGR of 7.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Topical Hemostatic Agent market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Topical Hemostatic Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Topical Hemostatic Agent report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Medical topical hemostatic agent are used in the setting of surgery or trauma as adjuncts to maintain hemostasis. Topical hemostat products include gelatin sponges, collagens, fibrin sealants, and active thrombin preparations. These agents are applied locally to stop blood flow.
Global Medical Topical Hemostatic Agent market is projected to reach US$ 12690 million in 2029, increasing from US$ 8350 million in 2022, with the CAGR of 7.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Topical Hemostatic Agent market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Topical Hemostatic Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Topical Hemostatic Agent report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Medical Topical Hemostatic Agent Market Overview
1.1 Product Overview and Scope of Medical Topical Hemostatic Agent
1.2 Medical Topical Hemostatic Agent Segment by Type
1.2.1 Global Medical Topical Hemostatic Agent Market Value Comparison by Type (2023-2029)
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Medical Topical Hemostatic Agent Segment by Application
1.3.1 Global Medical Topical Hemostatic Agent Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 Global Medical Topical Hemostatic Agent Market Size Estimates and Forecasts
1.4.1 Global Medical Topical Hemostatic Agent Revenue 2018-2029
1.4.2 Global Medical Topical Hemostatic Agent Sales 2018-2029
1.4.3 Global Medical Topical Hemostatic Agent Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Topical Hemostatic Agent Market Competition by Manufacturers
2.1 Global Medical Topical Hemostatic Agent Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Topical Hemostatic Agent Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Topical Hemostatic Agent Average Price by Manufacturers (2018-2023)
2.4 Global Medical Topical Hemostatic Agent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Topical Hemostatic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Topical Hemostatic Agent, Product Type & Application
2.7 Medical Topical Hemostatic Agent Market Competitive Situation and Trends
2.7.1 Medical Topical Hemostatic Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Topical Hemostatic Agent Players Market Share by Revenue
2.7.3 Global Medical Topical Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Topical Hemostatic Agent Retrospective Market Scenario by Region
3.1 Global Medical Topical Hemostatic Agent Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Topical Hemostatic Agent Global Medical Topical Hemostatic Agent Sales by Region: 2018-2029
3.2.1 Global Medical Topical Hemostatic Agent Sales by Region: 2018-2023
3.2.2 Global Medical Topical Hemostatic Agent Sales by Region: 2024-2029
3.3 Global Medical Topical Hemostatic Agent Global Medical Topical Hemostatic Agent Revenue by Region: 2018-2029
3.3.1 Global Medical Topical Hemostatic Agent Revenue by Region: 2018-2023
3.3.2 Global Medical Topical Hemostatic Agent Revenue by Region: 2024-2029
3.4 North America Medical Topical Hemostatic Agent Market Facts & Figures by Country
3.4.1 North America Medical Topical Hemostatic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Topical Hemostatic Agent Sales by Country (2018-2029)
3.4.3 North America Medical Topical Hemostatic Agent Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Topical Hemostatic Agent Market Facts & Figures by Country
3.5.1 Europe Medical Topical Hemostatic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Topical Hemostatic Agent Sales by Country (2018-2029)
3.5.3 Europe Medical Topical Hemostatic Agent Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Topical Hemostatic Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Topical Hemostatic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Topical Hemostatic Agent Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Topical Hemostatic Agent Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Topical Hemostatic Agent Market Facts & Figures by Country
3.7.1 Latin America Medical Topical Hemostatic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Topical Hemostatic Agent Sales by Country (2018-2029)
3.7.3 Latin America Medical Topical Hemostatic Agent Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Topical Hemostatic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Topical Hemostatic Agent Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Topical Hemostatic Agent Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Topical Hemostatic Agent Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Topical Hemostatic Agent Sales by Type (2018-2029)
4.1.1 Global Medical Topical Hemostatic Agent Sales by Type (2018-2023)
4.1.2 Global Medical Topical Hemostatic Agent Sales by Type (2024-2029)
4.1.3 Global Medical Topical Hemostatic Agent Sales Market Share by Type (2018-2029)
4.2 Global Medical Topical Hemostatic Agent Revenue by Type (2018-2029)
4.2.1 Global Medical Topical Hemostatic Agent Revenue by Type (2018-2023)
4.2.2 Global Medical Topical Hemostatic Agent Revenue by Type (2024-2029)
4.2.3 Global Medical Topical Hemostatic Agent Revenue Market Share by Type (2018-2029)
4.3 Global Medical Topical Hemostatic Agent Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Topical Hemostatic Agent Sales by Application (2018-2029)
5.1.1 Global Medical Topical Hemostatic Agent Sales by Application (2018-2023)
5.1.2 Global Medical Topical Hemostatic Agent Sales by Application (2024-2029)
5.1.3 Global Medical Topical Hemostatic Agent Sales Market Share by Application (2018-2029)
5.2 Global Medical Topical Hemostatic Agent Revenue by Application (2018-2029)
5.2.1 Global Medical Topical Hemostatic Agent Revenue by Application (2018-2023)
5.2.2 Global Medical Topical Hemostatic Agent Revenue by Application (2024-2029)
5.2.3 Global Medical Topical Hemostatic Agent Revenue Market Share by Application (2018-2029)
5.3 Global Medical Topical Hemostatic Agent Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Ethicon
6.1.1 Ethicon Corporation Information
6.1.2 Ethicon Description and Business Overview
6.1.3 Ethicon Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Ethicon Medical Topical Hemostatic Agent Product Portfolio
6.1.5 Ethicon Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Medical Topical Hemostatic Agent Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Baxter International
6.3.1 Baxter International Corporation Information
6.3.2 Baxter International Description and Business Overview
6.3.3 Baxter International Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Baxter International Medical Topical Hemostatic Agent Product Portfolio
6.3.5 Baxter International Recent Developments/Updates
6.4 C. R. Bard
6.4.1 C. R. Bard Corporation Information
6.4.2 C. R. Bard Description and Business Overview
6.4.3 C. R. Bard Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 C. R. Bard Medical Topical Hemostatic Agent Product Portfolio
6.4.5 C. R. Bard Recent Developments/Updates
6.5 The Medicines Company
6.5.1 The Medicines Company Corporation Information
6.5.2 The Medicines Company Description and Business Overview
6.5.3 The Medicines Company Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.5.4 The Medicines Company Medical Topical Hemostatic Agent Product Portfolio
6.5.5 The Medicines Company Recent Developments/Updates
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Corporation Information
6.6.2 Anika Therapeutics Description and Business Overview
6.6.3 Anika Therapeutics Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Anika Therapeutics Medical Topical Hemostatic Agent Product Portfolio
6.6.5 Anika Therapeutics Recent Developments/Updates
6.7 Advanced Medical Solutions
6.6.1 Advanced Medical Solutions Corporation Information
6.6.2 Advanced Medical Solutions Description and Business Overview
6.6.3 Advanced Medical Solutions Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Advanced Medical Solutions Medical Topical Hemostatic Agent Product Portfolio
6.7.5 Advanced Medical Solutions Recent Developments/Updates
6.8 Integra LifeSciences
6.8.1 Integra LifeSciences Corporation Information
6.8.2 Integra LifeSciences Description and Business Overview
6.8.3 Integra LifeSciences Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Integra LifeSciences Medical Topical Hemostatic Agent Product Portfolio
6.8.5 Integra LifeSciences Recent Developments/Updates
6.9 B Braun Melsungen
6.9.1 B Braun Melsungen Corporation Information
6.9.2 B Braun Melsungen Description and Business Overview
6.9.3 B Braun Melsungen Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.9.4 B Braun Melsungen Medical Topical Hemostatic Agent Product Portfolio
6.9.5 B Braun Melsungen Recent Developments/Updates
6.10 Gelita Medical
6.10.1 Gelita Medical Corporation Information
6.10.2 Gelita Medical Description and Business Overview
6.10.3 Gelita Medical Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Gelita Medical Medical Topical Hemostatic Agent Product Portfolio
6.10.5 Gelita Medical Recent Developments/Updates
6.11 Equimedical
6.11.1 Equimedical Corporation Information
6.11.2 Equimedical Medical Topical Hemostatic Agent Description and Business Overview
6.11.3 Equimedical Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Equimedical Medical Topical Hemostatic Agent Product Portfolio
6.11.5 Equimedical Recent Developments/Updates
6.12 Vascular Solutions
6.12.1 Vascular Solutions Corporation Information
6.12.2 Vascular Solutions Medical Topical Hemostatic Agent Description and Business Overview
6.12.3 Vascular Solutions Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Vascular Solutions Medical Topical Hemostatic Agent Product Portfolio
6.12.5 Vascular Solutions Recent Developments/Updates
6.13 Marine Polymer Technologies
6.13.1 Marine Polymer Technologies Corporation Information
6.13.2 Marine Polymer Technologies Medical Topical Hemostatic Agent Description and Business Overview
6.13.3 Marine Polymer Technologies Medical Topical Hemostatic Agent Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Marine Polymer Technologies Medical Topical Hemostatic Agent Product Portfolio
6.13.5 Marine Polymer Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Topical Hemostatic Agent Industry Chain Analysis
7.2 Medical Topical Hemostatic Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Topical Hemostatic Agent Production Mode & Process
7.4 Medical Topical Hemostatic Agent Sales and Marketing
7.4.1 Medical Topical Hemostatic Agent Sales Channels
7.4.2 Medical Topical Hemostatic Agent Distributors
7.5 Medical Topical Hemostatic Agent Customers
8 Medical Topical Hemostatic Agent Market Dynamics
8.1 Medical Topical Hemostatic Agent Industry Trends
8.2 Medical Topical Hemostatic Agent Market Drivers
8.3 Medical Topical Hemostatic Agent Market Challenges
8.4 Medical Topical Hemostatic Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
